{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:52:13Z","timestamp":1777567933563,"version":"3.51.4"},"reference-count":18,"publisher":"ALUNA","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:p>Aim: To investigate the impact of the initial choice between intravenous furosemide and torsemide on mortality outcomes and duration of hospital stay.\nMaterials and Methods: The prospective, open-label, comparative study included 68 adult patients hospitalized with acute heart failure (AHF). Furosemide was administered to 35 patients (51.5%) and torsemide to 33 patients (48.5%) during the first 48 hours after admission. Diuretic dosing was titrated according to urinary sodium concentration. After the initial 48 hours, further diuretic therapy was administered at the discretion of the attending physician. The primary endpoint was all-cause mortality, and the secondary endpoints were length of hospital stay and in-hospital mortality. \nResults: All-cause mortality was 51.4% in patients treated with furosemide and 42.4% in those treated with torsemide (p=0.478). The median survival time was 633 days (95% CI 178-1,259) in the furosemide group and 1,093 days (95% CI 541-1,239) in the torsemide group, with no statistically significant difference in survival between the two treatment groups (p=0.44). No in-hospital deaths occurred in the torsemide group, whereas four in-hospital deaths (11.4%) were observed in the furosemide group (p=0.115). The mean length of hospital stay was 12\u0081}7 days in both groups (p=0.551).\nConclusions: Both furosemide and torsemide showed no statistically significant differences in all-cause mortality, in-hospital mortality, and length of hospital stay.<\/jats:p>","DOI":"10.36740\/merkur202602103","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:57:58Z","timestamp":1777402678000},"page":"105","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure"],"prefix":"10.36740","volume":"54","author":[{"given":"Ma\u0142gorzata","family":"Ma\u0142ek-Elikowska","sequence":"first","affiliation":[{"name":"2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Szyszka","sequence":"additional","affiliation":[{"name":"2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julita","family":"Fedorowicz","sequence":"additional","affiliation":[{"name":"2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyntia","family":"Szyma\u0144ska-\u0141yczkowska","sequence":"additional","affiliation":[{"name":"2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Dankowski","sequence":"additional","affiliation":[{"name":"2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Baszko","sequence":"additional","affiliation":[{"name":"2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093\/eurheartj\/ehab368.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. Erratum: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(48):4901. doi:10.1093\/eurheartj\/ehab670.","DOI":"10.1093\/eurheartj\/ehab670"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3. D\u00edez J, Coca A, de Teresa E, Anguita M, Castro-Beiras A, Conthe P, et al. TORAFIC study protocol: torsemide prolonged release versus furosemide in patients with chronic heart failure. Expert Rev Cardiovasc Ther. 2009;7(8):897-904. doi:10.1586\/erc.09.74.","DOI":"10.1586\/erc.09.74"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4. L\u00f3pez B, Querejeta R, Gonz\u00e1lez A, S\u00e1nchez E, Larman M, D\u00edez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol. 2004;43(11):2028-2035. doi:10.1016\/j.jacc.2003.12.052.","DOI":"10.1016\/j.jacc.2003.12.052"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5. Cuthbert JJ, Clark AL. Diuretic treatment in patients with heart failure: current evidence and future directions. Part I: Loop diuretics. Curr Heart Fail Rep. 2024;21(2):101-114. doi:10.1007\/s11897-024-00643-3.","DOI":"10.1007\/s11897-024-00643-3"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Cuthbert JJ, Francis JGF, Clark AL. Diuretic treatment in patients with heart failure: current evidence and future directions. Part II: Combination therapy. Curr Heart Fail Rep. 2024;21(2):115-130. doi:10.1007\/s11897-024-00644-2.","DOI":"10.1007\/s11897-024-00644-2"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(10):1178-1195. doi:10.1016\/j.jacc.2019.12.059.","DOI":"10.1016\/j.jacc.2019.12.059"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. Cos\u00edn J, D\u00edez J. Torsemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail. 2002;4(4):507\u2013513. doi:10.1016\/S1388-9842(02)00122-8.","DOI":"10.1016\/S1388-9842(02)00122-8"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9. Imaeda S, Shiraishi Y, Kohsaka S, Niimi N, Goda A, Nagatomo Y, et al. Use of short-acting vs long-acting loop diuretics after heart failure hospitalization. ESC Heart Fail. 2022;9(5):2967-2977. doi:10.1002\/ehf2.14030.","DOI":"10.1002\/ehf2.14030"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, et al. Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial. JAMA. 2023;329(3):214-223. doi:10.1001\/jama.2022.23924.","DOI":"10.1001\/jama.2023.5291"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11. Mentz RJ, Hasselblad V, DeVore AD, Metra M, Voors AA, Armstrong PW, et al. Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF trial). Am J Cardiol. 2016;117(3):404-411. doi:10.1016\/j.amjcard.2015.10.059.","DOI":"10.1016\/j.amjcard.2015.10.059"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12. Li X, Si J, Liu Y, Xu D. Real-world experience in effect of torsemide vs furosemide after discharge in patients with HFpEF. ESC Heart Fail. 2025;12(1):71-79. doi:10.1002\/ehf2.15071.","DOI":"10.1002\/ehf2.15071"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13. Singh S, Goel S, Duhan S, Chaudhary R, Garg A, Tantry US, et al. Effect of furosemide versus torsemide on hospitalizations and mortality in patients with heart failure: a meta-analysis of randomized controlled trials. Am J Cardiol. 2023;206:42-48. doi:10.1016\/j.amjcard.2023.08.079.","DOI":"10.1016\/j.amjcard.2023.08.079"},{"key":"ref13","unstructured":"14. Clasen W, Khartabil T, Imm S, Kindler J. Torasemide for diuretic treatment of advanced chronic renal failure. Arzneimittelforschung. 1988;38(1A):209-211."},{"key":"ref14","unstructured":"15. Stroobandt R, Dodion L, Kesteloot H. Clinical efficacy of torsemide, a new diuretic agent, in patients with acute heart failure: a double-blind comparison with furosemide. Arch Int Pharmacodyn Ther. 1982;260(1):151-158."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Ma\u0142ek-Elikowska M, Szyszka A, Fedorowicz J, Dankowski R, Szyma\u0144ska C, Baszko A. Comparative analysis of furosemide and torsemide efficacy in 24 hours of acute heart failure admission. Front Pharmacol. 2025;16:1643077. doi:10.3389\/fphar.2025.1643077.","DOI":"10.3389\/fphar.2025.1643077"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17. Biegus J, Zymli\u0144ski R, Sokolski M, Todd J, Cotter G, Metra M, et al. Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure. Eur J Heart Fail. 2019 May;21(5):624-633. doi: 10.1002\/ejhf.1428.","DOI":"10.1002\/ejhf.1428"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18. Damman K, Ter Maaten JM, Coster JE, Krikken JA, van Deursen VM, Krijnen HK, et al. Clinical importance of urinary sodium excretion in acute heart failure. Eur J Heart Fail. 2020 Aug;22(8):1438-1447. doi: 10.1002\/ejhf.1753.","DOI":"10.1002\/ejhf.1753"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:58:10Z","timestamp":1777402690000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek20026i2net.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202602103","relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}